Name: GRDN Income Statement - Guardian Pharmacy Services Revenue & EPS | Ledgeburg
Creator: Ledgeburg
License: https://creativecommons.org/licenses/by/4.0/
Keywords: Revenue, Cost of Revenue, Gross Profit, Operating Expenses, Operating Income, Net Income, EPS Basic, EPS Diluted

JavaScript is disabled. Some features may not work properly. For the best experience, please enable JavaScript in your browser.

GRDN - Guardian Pharmacy Services, Inc.

USD | NYSE | Consumer Cyclical

GRDN Income Statement - Guardian Pharmacy Services Revenue & EPS | Ledgeburg

(in millions of USD, except per-share data)	Q1 FY 26	Q4 FY 25	Q3 FY 25	Q2 FY 25	Q1 FY 25	Q4 FY 24	Q3 FY 24	Q2 FY 24	Q1 FY 24	Q3 FY 23
Revenues
Revenues	336.6	397.6	377.4	344.3	329.3	338.6	314.4	300.0	275.4	262.7
Cost of Revenue	260.3	312.1	302.7	276.2	265.0	271.5	253.5	238.7	220.3	210.5
Gross Profit	76.3	85.5	74.7	68.1	64.3	67.1	60.9	61.3	55.1	52.2
Operating Expenses
Research & Development	-	-	-	-	-	-	-	-	-	-
Selling General & Administrative	58.6	54.7	58.4
Operating Income
Operating Income	17.7	30.8	16.4	12.6	13.0	16.8	(104.6)	17.0	7.9	(6.3)
Non-Operating
Interest Income	-	-	-	-	-	-	-	-	-	-
Interest Expense	0.2	0.2	0.2	0.2
Tax & Net
Income Tax Expense	4.7	9.8	7.0	3.8	3.8	4.4	0.2	0.0	0.0	-
Net Income From Continuing Ops	13.5	21.3	9.6
Per Share
EPS Basic	-	-	-	-	-	-	-	-	-	-
EPS Diluted	-	-	-	-
Supplementary Data
EBITDA	23.7	-	-	-	18.3	-	-	-	12.7	-
EBIT	17.7	30.8	16.4	12.6	13.0

Source: SEC EDGAR company filings. Figures as reported (US GAAP)

(in millions of USD, except per-share data)	TTM	FY2025	FY2024
Revenues
Revenues	1,456.0	1,448.7	1,228.4
Cost of Revenue	1,151.3	1,156.0	984.0
Gross Profit	304.7	292.7	244.4
Operating Expenses
Research & Development	-	-	-
Selling General & Administrative	227.3	220.0	307.3
Selling & Marketing	-	-	-
General & Administrative
Operating Income
Operating Income	77.4	72.7	(62.9)
Non-Operating
Interest Income	-	-	-
Interest Expense	0.6	0.7	3.3
Income From Equity Investments	-	-	-
Other Non-Operating Income
Tax & Net
Income Tax Expense	25.4	24.5	4.6
Net Income From Continuing Ops	53.2	49.0	(71.0)
Net Income From Discontinued Ops	-	-	-
Net Income
Per Share
EPS Basic	-	-	-
EPS Diluted	-	-	-
Shares Basic	-	-	-
Shares Diluted	-	-
Supplementary Data
EBITDA	-	95.0	(43.1)
EBIT	77.4	72.7	(62.9)

Source: SEC EDGAR company filings. Figures as reported (US GAAP)